Investors

China Medical System Holdings Limited (“CMS” or the “Group”, Hong Kong Stock Code: 867; Singapore Stock Code: 8A8) is an innovative pharmaceutical company focused on the identification, building, and full lifecycle management of differentiated specialty pharmaceuticals, dedicated to providing competitive products and services to meet unmet healthcare needs. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong Limited since 28 September 2010, and included in the Morgan Stanley Capital International (MSCI) Global Small Cap Indexes – China Index, Hang Seng Healthcare Index, Hang Seng Innovative Drug Index and HKEX Tech 100 Index, etc. The Group is the object of transaction in both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect. CMS has been ranked “AA” or “AAA” in MSCI-ESG ratings in the latest three years.